{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:03:00Z","timestamp":1791302580947,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2018.12.034","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T08:50:06Z","timestamp":1546591806000},"page":"882-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trends in U.S. Community hospitalizations due to herpes zoster: 2001\u20132015"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4788-9658","authenticated-orcid":false,"given":"Matthew A.","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bednarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund R.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-8209","authenticated-orcid":false,"given":"Walter A.","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.12.034_b0005","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recommend Rep: Morbid Mortal Week Rep Recommend Rep"},{"key":"10.1016\/j.vaccine.2018.12.034_b0010","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","article-title":"One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?","volume":"117","author":"Lopez","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.12.034_b0015","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recommend Rep: Morbid Mortal Week Rep Recommend Rep"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.12.034_b0020","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/jmv.10364","article-title":"Varicella in Americans from NHANES III: implications for control through routine immunization","volume":"70","author":"Kilgore","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2018.12.034_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.12.034_b0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/ajt.14683","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"18","author":"Dooling","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2018.12.034_b0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1089\/pop.2012.1561","article-title":"Discussing the zoster vaccine: an interview with Julie Gerberding, president of Merck vaccines","volume":"15","author":"Gerberding","year":"2012","journal-title":"Populat Health Manage"},{"key":"10.1016\/j.vaccine.2018.12.034_b0040","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","author":"Holmes","year":"1996","journal-title":"Morbid Mortal Week Rep: Recommend Rep"},{"key":"10.1016\/j.vaccine.2018.12.034_b0045","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.12.034_b0050","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1542\/peds.2004-0012","article-title":"Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States","volume":"114","author":"Davis","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2018.12.034_b0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.12.034_b0060","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.12.034_b0065","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/cid\/cis638","article-title":"Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy","volume":"55","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.034_b0070","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.12.034_b0075","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morbid Mortal Week Rep"},{"key":"10.1016\/j.vaccine.2018.12.034_b0080","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0025-6196(11)63996-7","article-title":"Varicella zoster viral disease","volume":"74","author":"Liesegang","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2018.12.034_b0085","doi-asserted-by":"crossref","first-page":"e0125025","DOI":"10.1371\/journal.pone.0125025","article-title":"Increasing trends of herpes zoster in Australia","volume":"10","author":"MacIntyre","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2018.12.034_b0090","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1016\/j.vaccine.2013.09.018","article-title":"Shingles in Alberta: before and after publicly funded varicella vaccination","volume":"32","author":"Russell","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.12.034_b0095","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1017\/S0950268811001786","article-title":"The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000\u20132008","volume":"140","author":"Chao","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2018.12.034_b0100","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv001","article-title":"Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, Connecticut, 1994\u20132012","volume":"2","author":"Humes","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2018.12.034_b0105","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.amepre.2016.08.029","article-title":"Herpes zoster vaccine coverage in older adults in the US, 2007\u20132013","volume":"52","author":"Zhang","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2018.12.034_b0110","unstructured":"Noninfluenza vaccination coverage among adults \u2013 United States, 2011. MMWR Morbid Mortal Week Rep 2013;62:66\u201372."},{"key":"10.1016\/j.vaccine.2018.12.034_b0115","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.ss6611a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"MMWR Surveill Summar"},{"key":"10.1016\/j.vaccine.2018.12.034_b0120","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.12.034_b0125","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc of Am"},{"key":"10.1016\/j.vaccine.2018.12.034_b0130","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00006454-199912000-00003","article-title":"Postmarketing evaluation of the safety and effectiveness of varicella vaccine","volume":"18","author":"Black","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.12.034_b0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70315-9","article-title":"Clinical trials of varicella vaccine in healthy children","volume":"10","author":"White","year":"1996","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.vaccine.2018.12.034_b0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/591975","article-title":"Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2018.12.034_b0145","first-page":"609","article-title":"Evolution of varicella surveillance\u2013selected states, 2000\u20132010","volume":"61","author":"Control CfD, Prevention","year":"2012","journal-title":"MMWR Morbid Mortal Week Rep"},{"key":"10.1016\/j.vaccine.2018.12.034_b0150","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005\u20132009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18317079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18317079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:40:58Z","timestamp":1551721258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18317079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X18317079"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in U.S. Community hospitalizations due to herpes zoster: 2001\u20132015","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}